癌症新药的获取速度偏好与生存益处的确定性：离散选择实验

文章预览

SCI 4 December 2024 Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment (IF: Lancet Oncol., 41.6) Forrest R, Lagarde M, Aggarwal A, Naci H. Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experiment. Lancet Oncol. 2024 Nov 18:S1470-2045(24)00596-5.  Correspondence to: Mr Robin Forrest, Department of Health Policy, London School of Economics and Political Science, London, WC2A 2AE, UK r.forest@lse.ac.uk Background 背景 The extent to which patients with cancer are willing to accept uncertainty about the clinical benefit of new cancer drugs in exchange for faster access is not known. This study aims to examine preferences for access versus certainty, and to understand factors that influence these preferences.  目前尚不清楚癌症患者在多大程度上愿意接受新抗癌药物临床益处的不确定性，以换取更快的获取途径。本 ………………………………